National Health Determination under paragraph 98C(1)(b) Amendment 2016 (No. 2) (PB 20 of 2016) (Cth)

PB 20 of 2016

National Health Determination under paragraph 98C(1)(b) Amendment 2016
(No. 2)

_____________________________________________________________________

I, PENNY SHAKESPEARE, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.

Dated    24 March 2016

PENNY SHAKESPEARE

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health

1              Name of Instrument

(1)This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2016 (No. 2).

(2)This Instrument may also be cited as PB 20 of 2016.

2              Commencement  

This instrument commences on 1 April 2016.

3              Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)

Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).

Schedule 1            Amendments

1. Schedule 3, after entry for Fentanyl in the form Lozenge 1600 micrograms (as citrate)

insert in the column headed “Form (strength, type, size, etc.)”:

Tablet (orally disintegrating) 100 microgram (as citrate)

Tablet (orally disintegrating) 200 microgram (as citrate)

Tablet (orally disintegrating) 400 microgram (as citrate)

Tablet (orally disintegrating) 600 microgram (as citrate)

Tablet (orally disintegrating) 800 microgram (as citrate)

1. Schedule 4, after entry for Alendronic acid with colecalciferol and calcium

insert:

Amino acid formula with fat, carbohydrate, without phenylalanine Tablet: modified release, 70.8 g protein per 100 g, 110 g (PKU Easy Microtabs)

1. Schedule 4, after entry for Ciprofloxacillin

insert:

Citrulline Tablet 1 g, 300 (Citrulline Easy)

1. Schedule 4, entry for Glucose Indicator—Blood

insert as first item in the column headed “Form (strength, type, size, etc.)”:

Test strips, 50 (2in1 Smart)

1. Schedule 4, after entry for Nedocromil

insert:

Netupitant with Palonosetron Capsule containing netupitant 300 mg with palonosetron 500 microgram (as hydrochloride)